Evaluation of the Prevalence of Oculomotor Disorders in Patients With Radiologically Isolated Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-26

Study Completion Date

2021-11-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the prevalence of subclinical oculomotor disorders in a population of patients with radiologically isolated syndrome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Studying Eye Movement Deficits and Cognitive Impairment in Patients with Multiple Sclerosis Using Infrared Eye Tracking and Cognitive Tests

NCT06629155

Multiple Sclerosis Internuclear Ophthalmoplegia

NOT_YET_RECRUITING

Dysfunctions and Plasticity Mechanisms of Motor System Assessed by Cortico-cortical and Cortico-muscular Coherence Analysis in Amyotrophic Lateral Sclerosis

NCT01959373

Amyotrophic Lateral Sclerosis

SUSPENDED NA

Impact of Neuropsychological Disorders in Multiple Sclerosis

NCT04837365

Multiple Sclerosis

RECRUITING NA

Electrophysiological Study of Spatiotemporal Gait Parameters in Patients in Early Stage of Multiple Sclerosis

NCT02896933

Multiple Sclerosis

COMPLETED

Assessment of Language Disorders in Multiple Sclerosis Patients

NCT04465084

Sclerosis Language Disorders

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Radiologically Isolated Syndrome (RIS) Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Neurological consultation group

Group Type EXPERIMENTAL

Neurological consultation

Intervention Type OTHER

study of horizontal, vertical, reflex and voluntary saccades, and of horizontal and vertical ocular pursuit by a BrainTracker eye-oculography system

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neurological consultation

study of horizontal, vertical, reflex and voluntary saccades, and of horizontal and vertical ocular pursuit by a BrainTracker eye-oculography system

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient must have given his informed consent and signed the consent form.
* The patient must be affiliated or beneficiary of a health insurance plan.
* The patient is at least 18 years old (≥) and under 50 years old (≤).
* Patients with radiologically isolated syndrome according to the criteria of Okuda et al. (2009)
* Diagnosis of a radiologically isolated syndrome confirmed by the national expert center of Nice for less than 3 years.

Exclusion Criteria

* The subject participates in another study.
* The subject is in an exclusion period determined by a previous study.
* The subject is under guardianship, curatorship or safeguard of justice.
* The patient is pregnant or breastfeeding
* The subject refuses to sign the consent.
* It is not possible to give the subject informed information.
* Patient presenting a pathological neurological examination.
* Patient with visual acuity less than 5/10 or with ocular instability

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No